Literature DB >> 2540972

Soluble and particulate Ins(1,4,5)P3/Ins(1,3,4,5)P4 5-phosphatase in bovine brain.

C Erneux1, M Lemos, B Verjans, P Vanderhaeghen, A Delvaux, J E Dumont.   

Abstract

Ins(1,4,5)P3 5-phosphatase catalyses the dephosphorylation of Ins(1,4,5)P3 in the 5 position. At 1 microM Ins(1,4,5)P3, 10-15% of total activity of a bovine brain homogenate was measured in the soluble fraction, whereas 85-90% was in the particulate fraction. Particulate activity could be solubilized by cholate or, to a lower extent, by 2 M KCl. Two soluble enzymes (type I and type II) could be fractionated by DEAE-Sephacel chromatography. Soluble activities have been further purified by blue-Sepharose, Sephacryl S-200 and phosphocellulose chromatography. Specific activities reached 10-30 mumol.min-1 mg protein-1 for type I and were 10-20 times lower for type II. Type I and type II Ins(1,4,5)P3 5-phosphatase displayed different Km values and molecular masses, as estimated by gel filtration. Type I dephosphorylated both Ins(1,4,5)P3 and Ins(1,3,4,5)P4; in contrast, type II specifically dephosphorylated Ins(1,4,5)P3 but not Ins(1,3,4,5)P4. Type I Ins(1,4,5)P3 5-phosphatase eluted as a single peak of activity with an apparent molecular mass of 51 kDa when gel filtration was performed in the presence of cholate. This molecular mass is identical to the molecular mass estimated for the particulate Ins(1,4,5)P3 5-phosphatase that was solubilized by cholate. Km values for Ins(1,4,5)P3 and Ins(1,3,4,5)P4 obtained with type I Ins(1,4,5)P3 5-phosphatase were 11 microM and 1 microM, respectively. Similar values were obtained with particulate Ins(1,4,5)P3 5-phosphatase. In conclusion, the catalytic domains of type I and particulate Ins(1,4,5)P3 5-phosphatase activity may be very similar, if not identical, but different from type II phosphatase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540972     DOI: 10.1111/j.1432-1033.1989.tb14726.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

1.  Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells.

Authors:  E Muraille; X Pesesse; C Kuntz; C Erneux
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

2.  Regeneration of soluble and particulate inositol 1,4,5-trisphosphate 5-phosphatase after SDS/polyacrylamide gel electrophoresis.

Authors:  F Hollande; B Verjans; C Erneux
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Synthetic inositol 1,3,4,5-tetrakisphosphate analogues.

Authors:  M Hirata; Y Kimura; T Ishimatsu; F Yanaga; T Shuto; T Sasaguri; T Koga; Y Watanabe; S Ozaki
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

4.  Underexpression of the 43 kDa inositol polyphosphate 5-phosphatase is associated with cellular transformation.

Authors:  C J Speed; P J Little; J A Hayman; C A Mitchell
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

5.  Cloning and expression in Escherichia coli of a dog thyroid cDNA encoding a novel inositol 1,4,5-trisphosphate 5-phosphatase.

Authors:  B Verjans; F De Smedt; R Lecocq; V Vanweyenberg; C Moreau; C Erneux
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

6.  Kinetic and inhibitor profiles of soluble and particulate inositol 1,4-5-trisphosphate 5-phosphatase from GH3 and IMR-32 cells.

Authors:  C J Fowler; G Brännström
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

7.  5-Stabilized phosphatidylinositol 3,4,5-trisphosphate analogues bind Grp1 PH, inhibit phosphoinositide phosphatases, and block neutrophil migration.

Authors:  Honglu Zhang; Ju He; Tatiana G Kutateladze; Takahiro Sakai; Takehiko Sasaki; Nicolas Markadieu; Christophe Erneux; Glenn D Prestwich
Journal:  Chembiochem       Date:  2010-02-15       Impact factor: 3.164

8.  Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5-trisphosphate 5-phosphatase and interaction with the PH domain of protein kinase Balpha.

Authors:  Stephen J Mills; Fabrice Vandeput; Melanie N Trusselle; Stephen T Safrany; Christophe Erneux; Barry V L Potter
Journal:  Chembiochem       Date:  2008-07-21       Impact factor: 3.164

9.  Multivalent benzene polyphosphate derivatives are non-Ca2+-mobilizing Ins(1,4,5)P3 receptor antagonists.

Authors:  Stephen J Mills; Tomas Luyten; Christophe Erneux; Jan B Parys; Barry V L Potter
Journal:  Messenger (Los Angel)       Date:  2012-12-01

10.  Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology.

Authors:  Kirsten Niebuhr; Sylvie Giuriato; Thierry Pedron; Dana J Philpott; Frédérique Gaits; Julia Sable; Michael P Sheetz; Claude Parsot; Philippe J Sansonetti; Bernard Payrastre
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.